FDA authorizes J&J 1-dose COVID vaccine

The Food and Drug Administration (FDA) today issued an emergency use authorization (EUA) for the Johnson & Johnson COVID-19 vaccine, giving the United States a third vaccine to fight the pandemic—one that offers an easier, one-dose option. The formal announcement follows yesterday's unanimous recommendation from the FDA's outside advisory panel, the Vaccines and Related Biological Products Advisory Committee (VRBPAC). In a statement, acting FDA Commissioner Janet Woodcock, MD, said vaccines are the best prevention in the fight against COVID-19.